Execution risk on capacity expansion
Planned 30-40% capacity expansion may face delays or cost overruns.
Sumeet Industries · Material risks, their source context, and severity in the latest available quarter.
ConCallIQ research layer
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Risk intelligence
Planned 30-40% capacity expansion may face delays or cost overruns.
Current margins may face pressure from competitive pricing and raw material volatility.
The ₹200 Cr rights issue could dilute existing shareholders' equity.
Direct export exposure is limited; benefits from trade deals are indirect and uncertain.